• Profile
Close

Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial

Journal of Clinical Lipidology Nov 10, 2017

Stroes ESG, et al. - In this study, researchers compared the intermediate dose of omega-3 carboxylic acids (OM3-CA, 2 g daily) to olive oil 2 g daily for efficacy and safety in reducing serum triglyceride (TG) and lipid concentrations in patients with severe hypertriglyceridemia (SHTG). Findings revealed that in addition to resulting in significant lowering in TG and non-high-density lipoprotein cholesterol (non-HDL-C) concentrations, an intermediate dose of OM3-CA (2 g daily) may benefit individuals at risk of acute pancreatitis and cardiovascular disease.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay